Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- FDA Approves New Indication for Abilify from BMS, Otsuka
September 22, 2003
- Tanabe Applies for Approval of Research Using Human ES Cells
September 22, 2003
- Alfressa Aims to Be No. 1 Wholesaler with \2 Tril. Sales by 2008
September 22, 2003
- Pathological Aging Must Be Overcome to Achieve Longevity: JPLA Seminar
September 22, 2003
- BUSINESS NEWS IN BRIEF
September 22, 2003
- PRESS SEMINAR
September 22, 2003
- REGULATORY NEWS IN BRIEF
September 15, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
September 15, 2003
- Kyowa Hakko Steps Up Patient Education Activities for Nocturnal Enuresis
September 15, 2003
- OTC NEWS IN BRIEF
September 15, 2003
- Fujisawa Establishes Centralized Drug Info Collection System
September 15, 2003
- DIAGNOSTIC NEWS IN BRIEF
September 15, 2003
- Sankyo Licenses Olmesartan to Pfizer
September 15, 2003
- MEDICAL DEVICE NEWS IN BRIEF
September 15, 2003
- Kyorin Signs Drug Discovery Agreement with DPI of the US
September 15, 2003
- WORLD NEWS IN BRIEF
September 15, 2003
- Kissei Awaiting Approval of Dry Mouth Treatment Pilocarpine
September 15, 2003
- Janssen Aims to Boost Nizoral Sales to \3 Bil.
September 15, 2003
- Dentsu Develops New Advertising Tool for Drug, Med Device Makers
September 15, 2003
- 4 New Drugs Incl. Livalo Added to NHI List
September 15, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…